Nanox AI

15/10/2026

18/08/2026

Expanding access to AI-supported bone health assessment in the UK.

Nanox AI has entered into an exclusive reseller agreement with Vertec Scientific for Nanox.AI bone solution (HealthOST) in the UK.

HealthOST analyzes eligible routine CT scans to support clinicians in the evaluation and assessment of musculoskeletal disease of the spine, such as osteoporosis, without additional imaging, radiation, or patient time.

Together with Vertec, we look forward to expanding access to this capability across the UK.

Read the full announcement to learn more about the collaboration: https://investors.nanox.vision/news-releases/news-release-details/nanox-and-vertec-scientific-enter-exclusive-sales-reseller

22/07/2026

Every day, millions of CT scans are performed worldwide, but much of the data within them remains underutilized.
This is where integrated Nanox.AI solutions can play a meaningful role.

Take a look at this study that shows and explores how Nanox.AI derived CAC scoring from existing CT scans can help characterize risk even when patients are not on therapy.

Explore how AI can support more from every scan.
Read the full article:
https://www.sciencedirect.com/science/article/abs/pii/S1934592526000869

To learn more, contact us [email protected]

16/07/2026

More insight from existing data
Nanox.AI solution - Results can be generated alongside routine processing, supporting clinical evaluation with quantitative data.

Lean More : https://www.nanox.vision/ai/

09/07/2026

New research from Journal of Cardiovascular Computed Tomography shows that Nanox.AI cardiac solution can detect CAC in non-cardiac CT scans, including in patients who are not receiving preventive therapy.

For patients who decline statin therapy, this kind of information may support more informed clinical discussions.

CAC detection - even when the scan wasn’t meant for the heart
Read the full article:
https://www.sciencedirect.com/science/article/abs/pii/S1934592526000869

To learn more, contact us [email protected]

08/07/2026

Join the Nanox.AI Sponsored Breakfast Symposium on Sunday at 7:30 AM: "From missed finding to missed opportunity: Aortic valve calcification on chest CT."
Enjoy breakfast at Sweet Bay while exploring the latest evidence and future opportunities with the Nanox.AI team.

Register here: https://forms.gle/52BioKpYoKiiLbpf8

hashtag

02/07/2026

“This really changes how we treat our patients. It allows us to detect plaque much earlier, engage in conversations about risk, and implement preventive measures earlier on in life.”- Ron Blankstein, MD.

Dr. Blankstein, Associate Director of the Cardiovascular Imaging Program at Brigham and Women’s Hospital and Professor at Harvard Medical School and an Advisory Board member of Nanox, shares how Nanox.AI cardiac solution enabled analysis of routine chest CTs may support earlier cardiovascular risk identification and population health strategies.

Watch the full testimonial:
https://youtu.be/ZJ0ROgfNwPo?si=x5iI5pYEWU50vgRE

To learn more, contact us [email protected]

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

24/06/2026

With osteoporosis affecting millions worldwide and vertebral compression fractures carrying significant clinical and economic impact, opportunistic screening may help support earlier intervention and preventive care strategies.
Nanox.AI Bone solution provides qualitative and quantitative analysis of the spine from CT images to support clinicians in the evaluation and assessment of musculoskeletal disease of the spine.
Nanox.AI is designed to integrate seamlessly into existing workflows, helping healthcare providers extract clinically meaningful insights from routine CT scans.
https://www.nanox.vision/ai-bone-solution/

To learn more, contact us: [email protected]

15/06/2026

“Osteoporosis is often silent until a fracture occurs.”

At the 251 Hellenic Air Force Hospital, Polyzois Makras, MD, Director of Dept. of Endocrinology & Diabetes and his team explored how Nanox.AI bone solution may support earlier identification of patients at risk for low bone density, using imaging data already available in routine care.

“In our pilot study with Nanox AI, we found cases of low bone density that routine practice could have missed. And this is a real game changer.”- Polyzois Makras, MD

Watch the full testimonial: https://www.youtube.com/watch?v=YdCPmjXCKLQ&t=18s

To learn more, contact us: [email protected]

10/06/2026

Bone health is already visible- but not always assessed.

Nanox.AI Bone solution: an AI-based analysis can aid identification of vertebral height loss and low bone mineral density - even when the scan wasn’t intended for osteoporosis evaluation.

Read more :https://www.nanox.vision/wp-content/uploads/2026/04/v0.3-HealthOST-WCO-poster.pdf

To learn more, contact us: [email protected]